A trial to evaluate the response of denosumab in postmenopausal women with osteoporosis
Latest Information Update: 18 May 2016
Price :
$35 *
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 18 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases